Literature DB >> 6750123

Antimalarials. 13. 5-Alkoxy analogues of 4-methylprimaquine.

M P LaMontagne, A Markovac, M S Khan.   

Abstract

A series of nuclear and side-chain analogues of 4-methylprimaquine incorporating an alkoxy group in the 5-position of the quinoline nucleus has been prepared. The compounds were tested for suppressive antimalarial activity against Plasmodium berghei in mice and for radical curative antimalarial activity against Plasmodium cynomolgi in the rhesus monkey. Although the toxicity problems characteristic of the 8-aminoquinolines were not overcome, several of the compounds, surprisingly, were highly effective as both blood and tissue schizonticidal agents.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6750123     DOI: 10.1021/jm00350a016

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

1.  Synthesis and anti-breast cancer activities of substituted quinolines.

Authors:  Aibin Shi; Thu A Nguyen; Srinivas K Battina; Sandeep Rana; Dolores J Takemoto; Peter K Chiang; Duy H Hua
Journal:  Bioorg Med Chem Lett       Date:  2008-04-13       Impact factor: 2.823

2.  Protection of retinal cells from ischemia by a novel gap junction inhibitor.

Authors:  Satyabrata Das; Dingbo Lin; Snehalata Jena; Aibin Shi; Srinivas Battina; Duy H Hua; Rachel Allbaugh; Dolores J Takemoto
Journal:  Biochem Biophys Res Commun       Date:  2008-06-30       Impact factor: 3.575

3.  Fungal metabolism of 4-methylprimaquine.

Authors:  A M Clark; J D McChesney; C D Hufford
Journal:  Pharm Res       Date:  1986-06       Impact factor: 4.200

4.  Synthesis and Biological Evaluation of 8-Quinolinamines and Their Amino Acid Conjugates as Broad-Spectrum Anti-infectives.

Authors:  Meenakshi Jain; C V Ravi P Reddy; Moumita Halder; Savita Singh; Randheer Kumar; Sagar Gajbe Wasudeo; Prati Pal Singh; Shabana I Khan; Melissa R Jacob; Babu L Tekwani; Rahul Jain
Journal:  ACS Omega       Date:  2018-03-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.